Your session is about to expire
← Back to Search
Relational Agent and heart rate and rhythm monitor for Atrial Fibrillation (AFibLITT Trial)
N/A
Waitlist Available
Led By Jared W Magnani, MD, MSc
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4, 8 and 12 months
Awards & highlights
AFibLITT Trial Summary
This trial looks at whether a self-care intervention can help people with atrial fibrillation (a heart condition). The intervention includes teaching people how to manage their disease and giving them support.
Eligible Conditions
- Atrial Fibrillation
- Arrhythmia
- Heart Disease
- Pathology
AFibLITT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4, 8 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4, 8 and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of Days Covered
Secondary outcome measures
Change from baseline Atrial Fibrillation Effect on QualiTy of life (AFEQT) at 4, 8 and 12 months
Days of hospitalization
Emergency room visits
+2 moreAFibLITT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention armExperimental Treatment1 Intervention
Receive the relational agent coupled with the AliveCor Kardia heart rate and rhythm monitor for 120-day use.
Group II: Usual care armActive Control1 Intervention
Receive a brochure on atrial fibrillation, the WebMD app and the AliveCor Kardia heart rate and rhythm monitor for 120-day use.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Relational Agent and heart rate and rhythm monitor
2020
N/A
~250
Find a Location
Who is running the clinical trial?
Boston UniversityOTHER
454 Previous Clinical Trials
9,941,327 Total Patients Enrolled
3 Trials studying Atrial Fibrillation
1,770 Patients Enrolled for Atrial Fibrillation
University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,342,098 Total Patients Enrolled
13 Trials studying Atrial Fibrillation
4,343 Patients Enrolled for Atrial Fibrillation
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,833 Previous Clinical Trials
47,306,253 Total Patients Enrolled
45 Trials studying Atrial Fibrillation
539,350 Patients Enrolled for Atrial Fibrillation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had a procedure called AV nodal ablation in the past or are expected to have it in the future.You have undergone or are planning to have a procedure called pulmonary vein isolation.You have been admitted to the hospital for heart failure within the past 3 months.You have an overactive thyroid that is not being treated, or you have been treated for an overactive thyroid for less than 3 months.You have other medical conditions, like a mechanical heart valve, blood clot in your leg, or a clot in your lung, that require you to take blood thinning medication.You had heart surgery within the past 3 months.You have a serious medical condition, like cancer, that could potentially cause death within the next year.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention arm
- Group 2: Usual care arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies left to be filled in this research endeavor?
"The clinical trial, posted on the 2nd of January 2020 and last edited on September 7th 2022, is no longer recruiting participants according to clinicaltrials.gov; however, 853 other studies are actively open for recruitment as we speak."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger